Herbalife Nutrition Ltd.
NYSE:HLFPackaged Foods
+$0.23 today
- Market cap
- $1.68B
- Beta
- 0.89
- P/E (TTM)
- 5.1
- EPS (TTM)
- $2.31
Volume 1.16M
Average 1.40M
HLF Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Herbalife Nutrition Ltd.NYSE: HLF
Gross Margin · Q1 FY2026 · quarter ended Mar 2026
Gross margin narrows to 75.6%
Gross margin was 75.6% in Q1 FY2026, down 2.7 pp from a year earlier. On a trailing-twelve-month basis it was 75.9%, down 2.2 pp year over year. Over 3 fiscal years it narrowed by 1.8 pp.
Context
- Gross margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 75.6%
- Year-over-year change
- -2.3pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 75.6% | -2.3pp |
| FY2024 | 2024-12-31 | 77.9% | +1.4pp |
| FY2023 | 2023-12-31 | 76.5% | -1.0pp |
| FY2022 | 2022-12-31 | 77.4% | -1.2pp |
| FY2021 | 2021-12-31 | 78.6% | — |
Gross Margin vs competitors
How HLF compares with its peers on the latest reported figures
- HLF's LTM Mar 2026 gross margin of 75.9% is the highest of the 7 companies compared; the peer median is 20.4%.
- Its year-over-year change of -2.2 pp is the 6th highest of 7, against a peer median of -0.3 pp.
- Over three fiscal years its change of -1.8 pp compares with a peer median of +1.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 75.9% | -2.2 pp | -1.8 pp | |
| LTM Mar 2026 | 41.0% | -1.6 pp | +1.1 pp | |
| LTM Mar 2026 | 29.2% | -0.6 pp | +1.9 pp | |
| LTM Mar 2026 | 22.3% | -12.6 pp | -9.5 pp | |
| LTM Mar 2026 | 18.5% | +0.1 pp | -2.5 pp | |
| LTM Mar 2026 | 13.9% | +4.4 pp | +7.0 pp | |
| LTM Apr 2026 | 12.3% | +1.3 pp | +3.0 pp | |
| Peer median (excluding HLF) | 20.4% | -0.3 pp | +1.5 pp | |
Competitors are the stored peer set for HLF. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.8B | 5.2B | 5.06B | 4.99B | 5.04B |
| Cost of Revenue | 1.24B | 1.17B | 1.19B | 1.1B | 1.23B |
| Gross Profit | 4.56B | 4.03B | 3.87B | 3.89B | 3.81B |
| Gross Margin | 78.6% | 77.4% | 76.5% | 77.9% | 75.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 2.01B | 1.81B | 3.53B | 3.51B | 3.45B |
| Operating Expenses | 3.83B | 3.49B | 3.52B | 3.5B | 3.37B |
| Depreciation & Amortization | 107.6M | 115.4M | 113.3M | 121.4M | 121.2M |
| EBITDA | 821.5M | 679.5M | 482.2M | 509.1M | 610.7M |
| EBITDA Margin | 14.2% | 13.1% | 9.5% | 10.2% | 12.1% |
| Operating Income | 734.1M | 545.2M | 356.4M | 385.9M | 441.5M |
| Operating Margin | 12.7% | 10.5% | 7.0% | 7.7% | 8.8% |
| Interest Income | 4.4M | 6.1M | 11.5M | 12.3M | 8.5M |
| Interest Expense | 153.1M | 139.3M | 165.9M | 218.3M | 214.4M |
| Other Income / Expenses | (173.3M) | (120.4M) | (153.4M) | (216.5M) | (166.4M) |
| Income Before Tax | 560.8M | 424.8M | 203M | 169.4M | 275.1M |
| Pre-Tax Margin | 9.7% | 8.2% | 4.0% | 3.4% | 5.5% |
| Income Tax Expense | 113.6M | 103.5M | 60.8M | (84.9M) | 46.8M |
| Net Income | 447.2M | 321.3M | 142.2M | 254.3M | 228.3M |
| Net Margin | 7.7% | 6.2% | 2.8% | 5.1% | 4.5% |
| EPS (Basic) | 4.22 | 3.26 | 1.44 | 2.53 | 2.22 |
| EPS (Diluted) | 4.13 | 3.23 | 1.42 | 2.50 | 2.20 |
| Weighted Avg Shares | 105.9M | 98.5M | 99M | 100.6M | 102.8M |
| Weighted Avg Shares (Diluted) | 108.3M | 99.5M | 100.2M | 101.6M | 103.6M |
Herbalife Nutrition Ltd.
NYSE:HLF
Intrinsic Alpha fair value
Locked
Current Price
$16.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.